Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers O > Headlines for Octapharma Nordic AB > News item |
S&P lifts Octapharma outlook to positive
Standard & Poor's said it revised its outlook on Octapharma Nordic AB to positive from stable.
At the same time, the agency said it affirmed the BB+ long-term corporate credit rating.
S&P noted that the outlook revision reflects Octapharma's continuing strong organic sales growth while it also reflects the positive steps taken toward increasing independence on the plasma supply market via investments into owned plasma sourcing centers and progress made in developing plasma recombinant technology.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.